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Circulating blood leucocyte telomere DNA content predicts vascular
wall telomere DNA content in humans with and without vascular
disease
W. R. W. Wilson, K. E. Herbert, B. Williams, M. M. Thompson
University Hospitals Nottingham and Leicester, and St George’s Hospital, London
Introduction: Telomere length is an index of cell age and replicative capacity.
Reduced telomere length in circulating leucocytes in humans is associated with
premature vascular disease and by implication, accelerated vascular ageing. A
link between telomere length in circulating leucocytes and the vessel wall has
never been established. We thus investigated the relationship between vascular
wall and circulating leukocyte telomere length in humans with and without
overt vascular disease.
Methods: Two subject groups were compared: 41 patients with asymptomatic
AAA, undergoing elective open repair, and 22 age-matched people with
morphologically normal aortas harvested at the time of cadaveric organ
donation. Telomere content was compared by quantitative PCR and expressed
as the telomere : genomic DNA ratio from aortic wall biopsies and blood
leucocytes.
Results: The telomere : genomic DNA content was significantly reduced
in wall biopsies of AAA versus normal aorta (AAA; 1·77 +/− 0·17, versus
normal aorta; 2·40 +/− 0·15, P = 0·001) and in the circulating leucocytes
of AAA versus normal aorta (AAA; 0·82 +/− 0·06, versus normal aorta;
1·27 +/− 0·21, P = 0·0003) and also after age- and gender-adjustment. There
was a strong correlation between leucocyte and vascular wall telomere content
in both diseased and healthy cohorts (AAA; r = 0·443, P = 0·050, normal aorta;
r = 0·676, P = 0·016). Taken together the correlation across all vessel and
blood leucocyte pairs was highly significant (r = 0·619, P = 0·0002).
Conclusion: The findings demonstrate that leucocyte DNA content is
predictive of vascular telomere content and is an accurate surrogate for human
vascular age. The significant correlation between vessel and leucocyte levels
supports a systemic process.
A comparison of aneurysmal and atheromatous aortic wall using a
whole transcriptome analysis reveals differential expression of a
number of novel genes
G. Chinien, K. G. Burnand, M. Waltham, A. Smith
Academic Department of Surgery, King’s College, London
Introduction: The objective of this study was to produce a gene expression
profile of human aneurysmal and atheromatous aortic wall.
Methods: cDNA was prepared from full thickness aortic wall obtained
during open abdominal aortic aneurysm repair and bypass for atheromatous
aortic disease (n = 5, each). The cDNA was hybridized to a HU133 plus
2·0 micro-array that interrogates the whole human genome. Data were analysed
using GeneSpring software. A significance threshold was set at P < 0·03 and
only genes that were consistently expressed with a two-fold difference were
considered.
Results: Two hundred and sixty-eight genes were differentially expressed
(fold change with p value). These included genes in the following
categories: i) proteolysis - folate hydrolase (2·8, P = 0·001), ADAM-9 (2·1,
P = 0·004), ubiquitin-specific peptidase-31 (2·4, P = 0·009); ii) inflammation
- interferon-γ receptor-1* (2·1, P = 0·0001), immunoglobulin g-1 (2·6,
P = 0·002), prostaglandin E synthase* (2·2, P = 0·004); iii) angiogenesis - alanyl
aminopeptidase (3·0, P = 0·017), angiopoietin-2 (2·2, P = 0·018), plexin-1 (2·1,
P = 0·02); iv) apoptosis - LIMS-1 (2·2, P < 0·0001), Apo E (3·0, P = 0·016),
effector cell peptidase receptor 1 (3·7, P = 0·01). (*Increased expression in AAA
wall.)
Conclusion: This micro-array study reveals novel genes that are differentially
expressed in abdominal aortic aneurysm wall. It also shows that MMPs are
equally expressed in aneurysmal and atheromatous aortic wall.
NT-pro B-natriuretic peptide is an independent predictor of
postoperative troponin-I release in patients undergoing major
vascular surgery
S. Rajagopalan, B. L. Croal, P. Bachoo, G. H. Hillis, B. H. Cuthbertson,
J. Brittenden
Aberdeen Royal Infirmary, Aberdeen
Introduction: Postoperative myocardial ischaemia remains the leading cause
of morbidity and mortality in patients undergoing major vascular surgery. Pre-
operative levels of B-type natriuretic peptide (BNP) released from myocardium
has been shown to be an independent predictor of cardiac events after major
non-cardiac surgery. We aimed to determine if the derivative N-Terminal-
proBNP (longer t1/2) can predict postoperative myocardial injury in vascular
patients.
Methods: One hundred and twenty-two patients undergoing elective surgery
for subcritical limb ischaemia or abdominal aortic aneurysm repair were
recruited. Patients in atrial fibrillation or chronic renal failure were excluded.
Plasma NT-proBNP was measured pre-operatively and daily samples for
troponin-I assayed until the fifth postoperative day.
Results: Twenty-four (20%) patients documented a postoperative myocardial
injury (troponin > 0·1 ng/ml). The median NT-proBNP of ‘troponin positive’
patients was significantly higher than those who were ‘troponin negative’ (380
pg/ml [inter-quartile range 223–967] versus 209 pg/ml [109–363], P = 0·003).
A cut-off value of 284 pg/ml was derived with a sensitivity = 71% and specificity
= 64% (AUC 70%). The pre-operative NT-proBNP levels above this threshold
remained an independent prognostic indicator of myocardial injury (odds ratio:
6·73, 95% c.i. 1·58–28·7, P = 0·01) after adjustment for cardiac risk factors,
hsCRP and interleukin-6 levels.
Conclusion: Elevated pre-operative plasma NT-proBNP levels independently
predict postoperative rise in troponin-I which is associated with adverse outcome
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in the short and long term regardless of the presence of symptoms or an acute
coronary syndrome.
Cigarette smoking is associated with impaired endothelial function in
human saphenous vein
M. A. Sharif1, U. Bayraktutan1, I. S. Young2, C. V. Soong2
1Belfast City Hospital and 2Queen’s University of Belfast, Belfast
Introduction: The aim of this ex vivo study was to assess the effect of smoking,
hypertension and diabetes mellitus on endothelial function in human saphenous
vein, a commonly used conduit for coronary and peripheral arterial bypass
surgery.
Methods: A segment of long saphenous vein harvested during infra-inguinal
bypass surgery was divided into 3–5mm rings. Rings were mounted in an organ
bath for isometric tension studies. Vein rings were pre-contracted to submaximal
contraction with phenylephrine, followed by endothelium-dependent relaxation
with acetylcholine. Comparison of contraction-response curves was evaluated
by two-way analysis of variance for repeated measures (two-way ANOVA).
Results: Long saphenous vein segments were collected from 26 patients,
including five females, with a mean age of 66·4 years (48–92). Current smokers
had impaired endothelium- dependent relaxation compared to ex and non-
smokers (10·2%, n = 13 versus 32·9%, n = 13, P < 0·01). However, ex-smokers
and non-smokers did not have a significant difference in relaxant responses to
acetylcholine (29·1%, n = 8 versus 24·6%, n = 5, P = ns). Similarly, diabetic
and non-diabetic patients did not show a significant difference in endothelium-
dependent relaxation (23·1%, n = 10 versus 15·6%, n = 16, P = ns). The
relaxant responses in hypertensive and normotensive patients were not different
(20·4%, n = 12 versus 22·5%, n = 14, P = ns).
Conclusion: The current smokers show a significant reduction in the
endothelial function of saphenous vein as compared to ex and non-smokers.
However, there was no difference in endothelial relaxation in ex versus non-
smokers. Thus, this study highlights the significance of impaired endothelial
function as one of the mechanisms by which smoking can compromise the
patency of vein graft.
The biomechanical and physical properties of connective tissue in
patients with abdominal aortic aneurysm
P. M. Bevis, J. F. Tarlton, R. A. J. Windhaber, D. C. Mitchell
Southmead Hospital and University of Bristol, Bristol
Introduction: To investigate a suggested link between abdominal aortic
aneurysm (AAA) formation and systemic connective tissue changes by studying
the physical and biomechanical properties of the skin and rectus sheath of
patients with AAA and controls without.
Methods: Site-matched samples of skin and rectus sheath were obtained from
patients undergoing elective open AAA repair and from controls undergoing
elective laparotomies for non-inflammatory colorectal disease. Samples were
prepared using a cutting jig before being tested on an Instron 6022 mechanical
test frame. Thickness of skin and rectus sheath was measured using video
microscopy.
Results: There was no difference in the maximum load to break, maximum
stress, maximum displacement to break or Young’s modulus between the skin or
rectus sheath of aneurysm patients and controls (P > 0·05, t-test). There was no
difference in the thickness of skin from aneurysm patients (2·87 mm) or controls
(2·58 mm) (P > 0·05, t-test). The rectus sheath of aneurysm patients (3·00 mm)
was significantly thicker than that of controls (1·83 mm) (P = 0·0399, t-test).
Conclusion: To our knowledge this technique has not been applied before
to the connective tissue of either group of patients. For a small sample group
there is no difference in biomechanical characteristics of the connective tissue
between patients with AAA and other patients undergoing laparotomy, despite
the rectus sheath being thicker in aneurysm patients. This leads us to believe
any connective tissue difference is likely to be represented in altered collagen
type or markers of collagen metabolism.
Elevated plasma MMP-9 is associated with increased 30-day mortality
in ruptured abdominal aortic aneurysms
W. R. W. Wilson, M. Anderton, E. Choke, J. Dawson, I. Loftus,
M. M. Thompson
University Hospitals Nottingham and Leicester, and St George’s Hospital, London
Introduction: The role of matrix metalloproteinases (MMPs) in aneurysm
development and rupture is well described. However, a clear role for plasma
MMPs in disease prediction has proved elusive. The plasma concentrations
of various MMPs have been reported to predict the natural history of small
AAAs. The elevation of specific MMPs within the vessel wall of ruptured AAA
is observed but a change in plasma MMP levels at the time of rupture has not
been described. The aim of this study was to determine if circulating levels of
MMPs and their endogenous tissue inhibitors (TIMPs) reflect the clinical state
of an AAA, namely stable versus ruptured.
Methods: Concentrations of MMP-1, MMP-2, MMP-3, MMP-9, and their
endogenous tissue inhibitor TIMP-1 were quantified using ELISA in plasma
samples taken pre-operatively from non-ruptured (n = 52) and ruptured AAA
(n = 16). Statistical analysis used the Mann-Whitney U test (P < 0·05).
Results: MMP-1 and MMP-9 were elevated in the plasma of ruptured AAA
versus non-ruptured AAA (MMP-1; rupture, 20·2ng/ml [16·1–28·7] versus
non-rupture, 8·9ng/ml [5·6–15·7], P < 0·0001: MMP-9; rupture, 59·1ng/ml
[20·8–123·7] versus non-rupture, 17·5ng/ml [10·3–34·2], P = 0·006). Death at,
or within 30 days of surgery for ruptured AAA was associated with a four-fold
elevation in pre-operative MMP-9 compared with those surviving for greater
than 30 days (mortality ≤ 30 days [n = 5], 131·9 ng/ml [75·5–191·8] versus
mortality > 30 days [n = 11], 32·2 ng/ml [5·9–129·5], P = 0·017).
Conclusion: In conclusion, these findings further support the role of MMPs
in AAA pathogenesis. Elevated plasma MMP-9 is associated with aneurysm
rupture and 30-day mortality. Inhibition or suppression of MMP-9 may offer
the very real possibility of improving survival from rupture.
Membrane Type-1 matrix metalloproteinase: a key player in carotid
plaque instability and symptomatic carotid atherosclerotic disease
K. Sritharan, D. Essex, A. Sandison, M. Ellis, C. Monaco, A. H. Davies
Department of Vascular Surgery, Charing Cross Campus and the Kennedy Institute of
Rheumatology Division (KIR), Imperial College, London
Introduction: To evaluate the role of Membrane Type-1 matrix metallo-
proteinase (MT1-MMP), a membrane-bound enzyme capable of degrading the
extracellular matrix of the fibrous cap, as a mediator of carotid plaque instability.
Methods: Tissue samples from patients undergoing carotid endarterectomy
(20 symptomatic, 8 asymptomatic, Gray-Weale classification range 1–4) were
immunostained for MT1-MMP. Percentage immunopositivity for MT1-MMP
in five regions of interest within each plaque was assessed using image analysis
software (AnalySIS). MT1-MMP mRNA expression was evaluated by reverse
transcription quantitative polymerase chain reaction (RT-QPCR). Age, sex,
degree of stenosis and statin usage were used as adjustment variables.
Results: MT1-MMP staining was scant on intact fibrous caps but was strong
at the site of fibrous cap rupture. The crude staining was 23·4% for ruptured
caps versus 2·24% for intact fibrous caps, P = 0·0028, and remained similar after
adjustment; plaques with higher Gray-Weale scores had an increased presence
of ruptured plaques, χ2, P = 0·0001. Higher levels of MT1-MMP mRNA were
found in symptomatic versus asymptomatic plaques, unit difference 3·15 (95%
c.i. 0·41 to 5·88), P = 0·027, and adjusted results were very similar; there was
no correlation with Gray-Weale score.
Conclusion: MT1-MMP is expressed at the site of fibrous cap rupture and at
increased levels within symptomatic carotid plaques. This suggests that MT1-
MMP has a critical role in carotid plaque instability and the genesis of carotid
symptoms.
Characterisation of fractalkine/CX3CL1 and fractalkine receptor
(CX3CR1) expression in abdominal aortic aneurysm disease
A. Patel, V. P. Jagadesham, K. E. Porter, S. R. Carding, D. J. A. Scott
Leeds Vascular Institute, Leeds
Introduction: Chronic inflammation and vascular smooth muscle cell (vSMC)
apoptosis is an emerging concept in the development of AAA disease. Recent
studies have demonstrated NK-cells from AAA patients display increased
cytotoxicity to vSMC. The chemokine, fractalkine (CX3CL1), is expressed
on vSMC and promotes adhesion and extravasation of leucocytes through
interactions with the receptor CX3CR1. This study aims to analyse expression
of CX3CL1 and CX3CR1 in AAA disease.
Methods: Immunohistochemistry (IHC) was used to define expression of
CX3CR1 in AAA tissue (n = 31). Multi-parametric flow cytometry (FC) was
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used to determine CX3CR1 expression on haematopoietic cells (CD45+), T-
cells (CD3+) and NK-cells (CD56+) obtained from peripheral blood (PB) of
AAA patients (n = 19). Percentage median values were calculated with IQR.
Results: IHC demonstrated CX3CR1+ cells in 20 out of 31 AAA tissues
with staining located primarily in either the media and adventitia. FC revealed
that 24·6% (22·3–26·8) of CD45+ cells were CX3CR1+; 8·04% (4·4–17·6) of
the CD45+ cells were CD56+/CX3CR1+; 68·6% (40·6–86·8) of all CD56+
NK-cells expressed CX3CR1. Only 10·6% (6·6–38·3) of CD3+ cells expressed
CX3CR1. In contrast CD3+ cells formed the highest percentage of CX3CR1+
cells in AAA tissue (20·9%, 14·2–27·4).
Conclusion: The findings suggest a role for the CX3CL1-CX3CR1 interaction
in the recruitment of inflammatory cells seen in AAA tissue. Analysis of
PB mononuclear cells from patients with AAA demonstrated a high level
of CD56+/CX3CR1+ NK-cells. The CX3CL1-CX3CR1 interaction could
contribute to the increased NK-cell cytotoxicity to vSMC.
Prevalence and correlation of hyperhomocysteinemia to
amputation-free survival (AFS), major adverse events (MAE) and
mortality after intervention for critical lower limb ischaemia (CLI) in
patients with peripheral vascular disease
H. M. Heneghan, W. Tawfick, S. Sultan
Western Vascular Institute, Galway, Republic of Ireland
Introduction: The relationship between hyperhomocysteinemia and patency
after PVD interventions has previously been inconclusive and controversial.
We aim to assess the prevalence and correlation of hyperhomocysteinemia
to clinical and technical outcome of revascularisation procedures for CLI.
Composite primary endpoints include primary and secondary patency rates,
AFS, MAE and all-cause mortality.
Methods: Between 2002 and 2006, 953 revascularisation procedures
were performed for CLI. Fasting plasma homocysteine was measured in
229 patients. The incidence of hyper-homocysteinemia was 30%. Mild
hyperhomocysteinaemia (13–20 µmol/L) was found in 88%. Patients with
normal and hyperhomocysteinemia were comparable.
Results: Primary patency rate for hyperhomocysteinemia patients was less than
half that of normal homocysteine patients (34·78% versus 73·88%, P < 0·0001).
There was a similar finding with respect to assisted primary patency rate,
though this was not statistically significant (25% versus 42%, P = 0·08).
There was no significant difference between groups with regards to secondary
patency rate. However, mean AFS was significantly shorter for patients with
hyperhomocysteinemia (31 versus 34 months, P = 0·008). Overall, 26% of the
normal homocysteine group progressed to vessel occlusion compared to 65%
of the hyperhomocysteinemia group (P < 0·0001). There was no significant
difference between groups with respect to 4-year cumulative all-cause mortality
(χ2 = 0·946). In addition, we found hyperfibrinogenemia to be an independent
significant variable associated with reduced primary patency rate and progression
to vessel occlusion.
Conclusion: We believe that hyperhomocysteinemia is an independent risk
factor for the progression of PVD and is an adverse prognostic factor for CLI
patients undergoing peripheral arterial revascularisation.
Increased SDF-1alpha and CXCR4 but not SDF-1beta expression in
human critical limb ischaemia
T. K. Ho1, S. Xu2, P. Leoni2, N. Aden2, C. DiSalvo3, R. Walesby3,
C. M. Black2, D. J. Abraham2, G. Hamilton1, D. M. Baker1
1Department of Surgery and 2Department of Rheumatology, The Royal Free and
University College Medical School, The Royal Free Hospital, London, and 3Department
of Cardiothoracic Surgery, The Heart Hospital, London
Introduction: SDF-1 plays a critical role in many physiological processes,
including stem cell homing and angiogenesis. SDF-1 has two spliced variants:
SDF-1alpha and SDF-1beta. We have previously shown that SDF-1beta has
more potent angiogenic properties compared to SDF-1alpha. The objective
of this study is to determine the pathophysiological expressions of the SDF-1
variants and its cognate receptor, CXCR4, in human critical limb ischaemia
(CLI).
Methods: Skeletal muscle biopsies were obtained from the lower limbs of
12 patients with CLI and 12 patients without limb ischaemia (controls), with
ethical committee approval. Immunohistochemistry localised the expressions of
SDF-1 variants and CXCR4. Double immunofluorescence labelling was used
to colocalise cell-specific antigens by confocal microscopy. SDF-1 variants and
CXCR4 protein expressions were evaluated by Western blotting. Statistical
analyses used the Mann-Whitney U test.
Results: In CLI, SDF-1alpha is extensively expressed by skeletal muscle
fibres but there was minimal expression of SDF-1beta. CXCR4 is extensively
expressed and is colocalised to microvessels. A significant 2·6-fold increased
protein expression (P < 0·05) of SDF-1alpha was noted in the CLI group.
There was no significant difference in the protein expressions of SDF-1beta
in both groups. CXCR4 expressions showed a 3·5-fold increase of protein
expression in the CLI group.
Conclusion: SDF-1alpha expression is localised to muscle fibres only and is
raised in CLI. However, there was minimal expression of SDF-1beta, either in
muscle fibres or microvessels. The lack of SDF-1beta may partly explain the
inadequate angiogenic response in CLI.
Topical wound oxygen (TWO2) versus conventional compression
dressings (CCD) in the management of refractory non-healing venous
ulcers (RVU); a parallel observational pivotal study in CEAP category
six patients
W. Tawfick, S. Sultan
Western Vascular Institute, Galway, Republic of Ireland
Introduction: TWO2 proposes an opportunity in the management of RVU.
The aim of this study is to prove the safety and efficacy of TWO2.
Methods: The primary endpoint is the proportion of ulcers healed, percentage
of reduction in ulcer size, time to full healing and bacterial elimination at the
end of therapy. Secondary endpoints are pain reduction and recurrence rates.
In the TWO2 group, the limb was placed in a TWO2 chamber for 180 min
bi-daily. The compression group was managed using Profore dressings.
Results: Forty-six chronic RVU of more than two years’ duration were
managed using TWO2 and 36 with CCD. Both groups were comparable.
All patients were classified as C6. At three months, 80% of TWO2-managed
ulcers (n = 37) were completely healed, compared to 25% (n = 9) of CCD
(P < 0·0001). Mean time to 70% reduction in surface area was 22 days in
the TWO2 group as opposed to 125 days in the CCD group (P < 0·0001).
Mean time to full healing or skin grafting was 62 days in TWO2 patients and
187 days in CCD (P < 0·0001). Seventeen ulcers were MRSA-positive, nine
of which became MRSA-negative after TWO2 treatment. This is compared
to 18 MRSA ulcers managed by CCD, all of which remained positive after
treatment (P = 0·033). The pain score threshold in the TWO2-managed
patients improved from eight to three by 13 days. After 3 months’ follow-
up, three of the nine healed CCD ulcers showed signs of recurrence compared
to none of the 37 TWO2 healed ulcers.
Conclusion: TWO2 is a valuable tool, safe and effective in managing chronic
RVU.
Intraluminal thrombus has a selective influence on matrix
metalloproteinases (MMPs) and their inhibitors (TIMPs) in the wall of
abdominal aortic aneurysms (AAAs)
M. N. A. Abdul Rahman, S. Gulati, M. Mekako, P. T. McCollum,
I. C. Chetter
Academic Vascular Surgery Unit, Hull Royal Infirmary, Hull
Introduction: The influence of intraluminal thrombus on the proteolytic
environment within the wall of an abdominal aortic aneurysm is unknown. We
aimed to assess the influence of intraluminal thrombus on the expression and
activity of MMPs and TIMPs within the adjacent AAA wall.
Methods: Thirty-five patients, 26 men, median age 73 (range 66-82) years
undergoing elective repair of AAAs were studied. A full thickness AAA wall
specimen was taken from each patient and the exact position was noted. All
samples were snapped frozen and analysed for MMP-2, -8 and -9 and TIMP-
1 and -2 using ELISA. Statistical analysis was performed using SPSS v14.
Thrombus thickness at specimen sites was measured on the pre-operative CT
scan.
Results: Active concentration of MMP-9 and TIMP-1 were significantly
positively correlated with thrombus thickness with a Pearson correlation
coefficient r of 0·45 and 0·42, respectively. MMP-2 (active and total) and
TIMP-2 showed a positive correlation although not statistically significant.
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MMP-8 (active and total) showed a non-significant negative correlation with
thrombus thickness.
Conclusion: Intraluminal thrombus thickness has a significant positive
correlation with active MMP-9 (elastase) and TIMP-1, and a negative
correlation with MMP-8 (collagenase). This may have some implication for
AAA expansion and rupture.
Patients with abdominal aortic aneurysms show changes in collagen
content and type in their connective tissue
P. M. Bevis, J. F. Tarlton, R. A. J. Windhaber, D. C. Mitchell
Southmead Hospital and University of Bristol, Bristol
Introduction: To see if the changes in collagen content and type seen in the
wall of abdominal aortic aneurysms (AAA) are also represented in the skin and
rectus sheath as part of a systemic connective tissue disorder.
Methods: Samples of skin and rectus sheath were obtained at the time of surgery
from patients undergoing elective open AAA repair and controls undergoing
laparotomy for non-inflammatory colorectal disease. Collagen content was
measured by hydroxyproline analysis. Collagen I : III ratio was analysed by using
interrupted reduction and polyacrylamide gel electrophoresis in the presence of
sodium dodecyl sulphate.
Results: There was a significantly reduced amount of total collagen content
in the skin of aneurysm patients compared to controls (P = 0·0015, t-test) but
no difference was seen in the collagen I : III ratio (P = 0·75, t-test). There was
no difference in the total collagen content of the rectus sheath between groups
(P = 0·54, t-test). AAA patients had a significantly higher collagen I : III ratio
than control patients (P = 0·044, t-test).
Conclusion: The increased collagen I : III ratio in the rectus sheath represents
a systemic reduction in type III collagen in aneurysm patients consistent with
changes seen in some familial aneurysms. Combined with the reduction in skin
collagen, this further supports the idea of aneurysmal disease as being part of a
systemic connective tissue disorder.
Vascular endothelial growth factor is over-expressed at the site of
abdominal aortic aneurysm rupture and promotes the formation of
angiotensin-II-induced aneurysms in apolipoprotein E-deficient mice
E. Choke, G. W. Cockerill, J. Dawson, F. Howe, K. Laing, A. Jones,
I. M. Loftus, M. M. Thompson
St George’s Hospital, University of London, London
Introduction: An abdominal aortic aneurysm (AAA) rupture site is associated
with increased angiogenesis but the significance of this is unknown. This study
identified candidate pro-angiogenic genes in a human AAA rupture site and
investigated the functional significance of VEGF in an angiotensin-II (Ang-II)
mouse aneurysm model.
Methods: Micro-array analysis and QRT-PCR validation studies were used to
identify differentially expressed (> 2·5-fold, P < 0·005) pro-angiogenic genes
at human aneurysm rupture sites (n = 10) using paired anterior sac as internal
controls. To investigate the role of VEGF, apo E−/− mice were assigned to
either: i) saline infusion (placebo control); ii) ang-II infusion (which induced
aneurysm formation); iii) ang-II infusion plus 14 days 100 mcg VEGF; or iv)
ang-II infusion plus 21 days 100 mcg VEGF. Aortic diameter and cross-sectional
area were determined by MRI at 21 and 28 days.
Results: Four pro-angiogenic genes (PROK2, IL8, ANGPTL4, VEGF) were
over-expressed at human aneurysm rupture sites. All mice in Ang-II+14dVEGF
and Ang-II+21dVEGF groups developed aneurysms by day 21 compared to
only 40% in the Ang-II infusion group. VEGF treatment increased diameter
and cross-sectional area of aneurysms at day 21 (P < 0·002) and this effect was
maintained at day 28 (P < 0·0005). Decreasing VEGF treatment from 21 to
14 days did not attenuate aneurysm formation. VEGF upregulated aortic wall
MMP-2 gene expression (P < 0·0009).
Conclusion: VEGF gene was over-expressed at human AAA rupture sites
and VEGF promoted formation of ang-II-induced aneurysms. Whether anti-
VEGF therapy reduces risks of aneurysm expansion or rupture merits further
investigations.
Quantitative bilateral photoplethysmography for peripheral arterial
disease detection: a prospective assessment
J. Allen, K. Overbeck, A. Murray, G. Stansby
Regional Medical Physics Department and Northern Vascular Centre, Freeman
Hospital, Newcastle-upon-Tyne
Introduction: To prospectively assess the diagnostic accuracy of a novel
bilateral photoplethysmography (PPG) toe pulse measurement technique for
the diagnosis of lower limb peripheral arterial disease (PAD).
Methods: Bilateral PPG toe pulse measurements were compared with ankle
to brachial pressure index (ABPI) reference measurements. The setting was
a controlled environment within a tertiary vascular surgical unit. Innovative
pulse wave analysis techniques (device winner of national NHS HSC Award
for Innovative Technology) extracted shape and timing characteristics from the
great toe sites and also their right-to-left side differences. These were compared
with our previously obtained normative ranges and the diagnostic performance
of detecting significant PAD (i.e. ABPI <0·9), assessed using accuracy and the
Kappa statistic (agreement between techniques beyond chance).
Results: One hundred and eleven subjects were studied (range 40–90 years),
with 63 normal and 48 PAD by ABPI. Subjects within the two ABPI groups
were matched in age, sex, height and heart rate. Substantial agreement between
pulse and ABPI classifications were obtained for the degree that pulse shape
fell beyond the normal range of normalized shapes (accuracy 91%, Kappa 0·80)
and also pulse transit time differences between the right and left toes (accuracy
86%, Kappa 0·70).
Conclusion: This technique could offer significant benefits for the diagnosis
of PAD in settings such as primary care where non-invasive, quick, affordable
and ‘de-skilled’ diagnostic techniques are desirable. Improved diagnosis and
screening for PAD has the potential to allow identification and cardiovascular
risk factor management for this group.
Skeletal muscle myosin heavy chain expression in claudicants; effect
of a supervised exercise programme
T. A. Beckitt, F. C. T. Smith, R. N. Baird, P. M. Lamont
Bristol Royal Infirmary, Bristol
Introduction: There is growing evidence that supervised exercise for
claudication exerts effects on local calf muscle metabolism. The relative
expression of the differing myosin heavy chains (MHCs) within skeletal muscle
is a key determinant of muscle metabolism. Compared to MHC II, MHC I
is better able to generate ATP, switching less rapidly to anaerobic metabolism
during prolonged physical activity. This study sought evidence of a shift in
MHC protein expression within gastrocnemius muscle as a result of supervised
exercise for claudication.
Methods: Thirty-seven claudicants were recruited. Subjects undertook a
three-month supervised exercise programme. Controls were patients awaiting
angioplasty for claudication. Both groups underwent paired gastrocnemius
needle biopsies. Relative MHC expression was determined by SDS gel
electrophoresis.
Results: Following exercise training, maximum walking distance (MWD)
increased by 109% (P < 0·01). At recruitment the relative MHC expression was
MHC I 34·3% (±6·8), MHC IIa 42·0% (±7·1) and MHC IIx 23·7% (±4·9).
Following supervised exercise training there was a significant increase in MHC
I expression +11·1% (±3·9, P < 0·05), not witnessed in the control group. The
largest shifts in MHC expression occurred in subjects with the greatest increases
in MWD.
Conclusion: Improved walking distance after supervised exercise training
for claudication is associated with an increase in MHC type I expression.
This increased MHC 1 expression may contribute to improved skeletal
muscle oxidative capacity and is worthy of further investigation as a means
to increase walking distance in patients unable to participate in supervised
exercise programmes.
The impact of a diabetic foot protection team (DFPT) on outcomes for
patients with diabetic vascular disease
G. Bowen, H. Barton, G. Haggan, J. Brooke, J. Sweet, S. Baxter,
C. P. Shearman
Southampton University Hospitals NHS Trust, Southampton
Introduction: Over 40% of patients with peripheral arterial disease (PAD)
have diabetes and this group have a worse prognosis; the majority of lower limb
amputations in the UK being performed for diabetic vascular disease. We set
out to identify methods to reduce the amputation rate for patients with diabetes.
Methods: A prospective database was established for patients with diabetic
foot complications. For 6 months a mapping exercise was undertaken to identify
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areas of poor practice. A protocol was then introduced and implemented by a
diabetic foot protection team (DFPT) working across primary and secondary
care. The results of the first 3 years of this project are presented.
Results: Minor amputations increased by 42%, but there was an overall 60%
reduction in major amputations carried out over 3 years. There was a 7% yearly
increase in patients treated, hospital admissions increased form 118 to 174
patients per year and revascularisation rates increased. However, despite this,
median length of hospital stay reduced from 47 to 19 days, saving 5662 bed
days (equating to £1·3 million savings). The DFPT also identified HRG coding
inaccuracies amounting to a potential £750, 000 loss to the service. Investment
in the service was £52, 000 per year.
Conclusion: We have demonstrated that a DFPT will reduce major
amputation rates and hospitalisation in patients with diabetes. It is highly
cost-effective, reducing length of stay by 60%. A national approach to the
problem of diabetic vascular disease could make a major impact on amputation
rates in the UK.
Inherent functional differences between saphenous vein smooth
muscle cells cultured from non-diabetic and Type 2 diabetic patients
H. A. Madi, N. A. Turner, D. J. O’Regan, K. E. Porter
Institute for Cardiovascular Research, University of Leeds, Leeds
Introduction: Compared with their non-diabetic counterparts, individuals
with Type 2 diabetes mellitus (T2DM) are at increased risk of coronary artery
disease and saphenous vein (SV) graft stenosis following coronary artery bypass
grafting (CABG). The primary cause of graft failure is intimal hyperplasia,
characterised by smooth muscle cell (SMC) proliferation and migration.
We hypothesised that SV-SMC from T2DM patients are intrinsically more
proliferative and migratory, thereby contributing to this difference.
Methods: SV-SMC were explanted from six non-diabetic and six T2DM
undergoing CABG. Cell proliferation was determined over 7 days in response to
10% foetal calf serum (FCS), or insulin (100 nM) combined with platelet-derived
growth factor (PDGF, 10 ng/ml). Migration was quantified with modified
Boyden chambers. Western blotting was used to assess activation of ERK-1/2
and AKT signalling pathways. Data were analysed using unpaired ratio t-tests.
Results: SV-SMC from T2DM were morphologically distinct from non-
diabetic patients and were less proliferative in 10% FCS (P < 0·01). The
proliferative rate of the two populations was similar in insulin+PDGF. In
the presence of insulin, the migratory capacity of diabetic SV-SMC was
significantly greater than those of non-diabetic patients (P < 0·05). All the
observed differences were independent of glucose concentration. No consistent
differences in ERK and AKT signalling existed between the two populations.
Conclusion: This study has revealed a number of inherent functional
differences between cultured SV-SMC from non-diabetic and T2DM patients
that may account for the inferior patency of SV bypass grafts in T2DM patients.
Determining the mechanisms underlying these effects may be of major clinical
importance.
Development of a vascular bypass graft with polyhedral oligomeric
silsequioxane nanocomposite (POSS PCU)
A. de Mel, S. Sarkar, N. Alobaid, A. Darbyshire, B. Ramesh,
A. M. Seifalian, G. Hamilton
Academic Division of Surgical and Interventional Sciences, Biomaterials and Tissue
Engineering Centre (BTEC), Royal Free and University College Medical School,
University College London, London
Introduction: It is desirable to have a compliant and spontaneously
endothelialising small diameter bypass graft. Therefore, it was aimed to: i)
use a nanocomposite-containing biomaterial, which has been shown to have
ideal properties for vascular implants to develop a graft; and ii) surface modify
the polymer with peptides/proteins, which have been recognised to adhere to
endothelial progenitor cells (EPC) and thus aimed to promote endothelialisation
of grafts.
Methods: Bioactive peptides RGD/protein stem cell factor were incorporated
and covalently attached to POSS PCU polymer and a coagulation technique was
used to produce 3·5mm bypass grafts. Changes in diameter of graft segments
were measured at physiological pulse pressure and flow, and diametrical
compliance was calculated over a range of mean pressures. Both modified
and unmodified graft segments were exposed to culture medium with peripheral
blood mononuclear cells containing EPC, and EPC adhesion was tested. Also,
the grafts were connected in a flow circuit and circulated with a similar EPC
culture medium. Confirmation of cell markers was carried out using FACS
analysis, RT-PCR and immunostaining.
Results: The grafts possess a porous interior and visco-elastic properties
with a greater degree of compliance match compared to Dacron/ePTFE.
Peptide/protein modification increased the number of EPC colonies and
exposure to flow led to differentiation of cells. Cells expressed mRNA for
the EPC markers CD34, CD31, CD133 and F1K-1/KDR. Endothelial cell-
colony forming units were formed and were confirmed as endothelial-like cells
by immunostaining.
Conclusion: A novel, compliant small diameter vascular bypass graft proved
the potential to endothelialise in situ.
The proposed 18-week target - is there time for investigations?
P. Bourke, C. D. Bicknell, S. Maxwell, J. Mayet, J. H. N. Wolfe,
R. G. J. Gibbs, N. J. W. Cheshire, M. P. Jenkins
Regional Vascular Unit, St Mary’s Hospital, London
Introduction: Major aortic cases require detailed cardiac, renal and respiratory
assessments. In light of current NHS initiatives to reduce length of stay (LOS)
and limit time from referral to treatment to 18 weeks, we examined the effect
of a dedicated nurse specialist to co-ordinate the work-up period.
Methods: With the appointment of a nurse specialist, clinic referrals were
managed based on investigation results according to a pre-determined protocol.
Dedicated diagnostic investigation slots and clinic appointments allowed timely
management. We studied 44 patients before (group 1) and 193 consecutive
patients after (group 2) employment of a nurse specialist. Data were collected
prospectively. Data are presented as median values with inter-quartile range.
Statistical analysis was performed using the Mann-Whitney U test.
Results: All patients in both groups completed a full set of investigations prior
to surgery or stenting. The median LOS in group 1 was 12 days (IQR 9–16),
compared with < 1 day (IQR 0–2) for group 2 with P < 0·001. This reduction
was largely due to the introduction of a co-ordinated day-case assessment, which
was used in 56% of group 2 compared with 0% of group 1. At a cost of £500
per bed day this equates to a saving of £1113 per patient.
Conclusion: Co-ordination of investigations by a dedicated nurse specialist
led to significant reductions in patient LOS. This should reduce costs, as well
as exposure to hospital- acquired infections and will contribute to meeting the
18-week target.
Litigation claims in vascular surgery in the United Kingdom
G. A. Markides, D. Subar, H. Al-Khaffaf
Burnley General Hospital, Burnley
Introduction: To establish the incidence, costs and causes of medical
negligence claims in relation to vascular surgery in the UK’s NHS.
Methods: All claims related to vascular surgery reported to the NHS Litigation
Authority from 1995 to April 2007 were included in the study. All data were
subsequently reviewed, coded accordingly and analysed.
Results: Three hundred and ninety-five claims were analysed (mean: 53/year
over the last five years) of which 303 have been settled. Of the latter,
compensation was given in 160 (53%) cases, with total claims’ compensation
ranging from £21 to £654, 819. The overall litigation costs were £169, 111, 65.
Successful claims varied from intra-operative problems (50%) (of which 75%
were related to varicose vein [VV] surgery and 13% to peripheral vascular disease
[PVD]), to failure/delay of treatment (14%), failure/delay of diagnosis (11%),
postoperative treatment (6%), inappropriate treatment (6%) and others (13%).
VV surgery was the most common type of disease/procedure involved in the
successful claims (48%, claim range £35–£485, 000, total claim £6·2 million), in
which intra-operative problems (66%) (60% nerve damage, 27% vessel damage),
postoperative complications (18%) and inappropriate treatment (7%) were
implicated. Other types of disease/procedures involved PVD (21%), abdominal
aortic aneurysm disease (6%), infections/ulcers (5%), medical treatment (5%)
and others (15%).
Conclusion: The number of claims related to vascular surgery has remained
stable over the past 5 years. In general, 50% of claims are due to intra-operative
complications, while problems related to VV form almost half of all successful
claims.
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Medium to long-term results of thoracic endografting
R. Qasabian, M. Davis, R. E. Bell, M. Waltham, T. W. G. Carrell,
T. Sabharwal, C. Sandhu, R. Salter, J. F. Reidy, P. R. Taylor
Departments of Vascular Surgery and Radiology, Guy’s and St Thomas’ NHS Trust,
London
Introduction: The long-term durability of thoracic stent grafting is still
unknown, especially given the thoracic aorta can be affected by a heterogeneous
group of pathologies. This study examines mid-long-term follow-up for
commercially available thoracic devices and aims to determine which variables
may be predictive of outcome.
Methods: Data were collected prospectively between July 1997 and July 2007
in a consecutive series of patients and analysed.
Results: Two hundred and thirteen patients (65% men) underwent thoracic
stent grafting for a variety of aortic pathologies. Median age was 71 years
and mean aneurysm size was 6·4 cm. Thirty-day mortality was 4·3% (6/140)
for elective and 9·6% (7/73) for urgent procedures. Paraplegia occurred in
4·2% (9/213) and was permanent in four (1·9%). Stroke occurred in 5·1%
(11/213). Median follow-up was 30 (range 0–119) months. Adjuvant procedures
were performed to optimise landing zone in 11·3%, to improve access using
conduits in 3·3% (n = 7), and for postoperative complications in 5·1% (n = 11).
Endoleaks were detected in 19·7% (42/213), and are on-going in 3·3% (7/213).
Secondary interventions were performed in 14·6% (n = 31), including six graft
explantations (four in dissection patients) and repair of two Type A conversions
of Type B dissection. Aneurysm-related death occurred late in 3·8% (8/213). At
median 30-month follow-up, 82·6% (176/213) have had successful treatment of
their thoracic aortic pathology.
Conclusion: These medium to long-term data show that thoracic endoluminal
devices are durable. The heterogeneity of the aortic pathology is reflected in
the fact that complex aneurysms and dissections have a worse outcome than
localised pathology (penetrating ulcers and small aneurysms), and therefore
ongoing surveillance is essential.
Endovascular management of traumatic thoracic aortic injury (TAI)
C. Bent, M. Matson, I. Renfrew, M. Sobeh, M. Walsh, K. Brohi,
C. Kyriakides
Barts and The London NHS Trust, London
Introduction: Endovascular repair for TAI, which occurs predominantly in
polytrauma patients, is a minimally invasive alternative to open surgery obviating
the need for thoracotomy and cardiac bypass. This study assesses the feasibility
of endovascular repair following blunt TAI at a single centre.
Methods: Data from 15 consecutive patients (mean age, 44 years; range,
16–84 years; sex, 3 females, 12 males) with a blunt TAI treated by endovascular
stent graft insertion between October 2001 and March 2007 were prospectively
collected. Demographics, injury characteristics, technique and complications
were recorded. Follow-up data included computed tomographic angiography
and plain chest radiography at regular intervals.
Results: All patients underwent endovascular repair within a median of
9 hours from hospital presentation (range 4–81 hours). Two patients underwent
carotico-carotid bypass immediately prior to stenting during a single anaesthetic.
The type of stent graft included Talent LPS/Valiant (n = 7), Excluder
(n = 6) and Relay (n = 2). Successful exclusion of the TAI occurred in all
patients. No procedure-related mortality, paraplegia and stroke were recorded.
Complications included proximal migration of initial stent graft requiring
surgical explantation in one patient and iliac artery avulsion requiring iliofemoral
bypass in two patients. Median hospital stay was 12 days (range 4–58 days).
Mean follow-up was 28·9 months (range 4–67 months).
Conclusion: In our study, endovascular repair of blunt TAI is a safe procedure
and can be employed as an alternative to open surgery.
Wholly endovascular repair of thoraco-abdominal aneurysm:
experience in a single UK centre
G. L. Gilling-Smith, J. R. Scurr, J. A. Brennan, R. K. Fisher, P. L. Harris,
S. R. Vallabhaneni, R. G. McWilliams
Regional Vascular Unit, Royal Liverpool University Hospital, Liverpool
Introduction: To evaluate the feasibility and safety of a purely endovascular
approach to the repair of thoraco-abdominal aortic aneurysm (TAAA).
Methods: Six patients (4 male, 2 female) with a median age of 71 years (range
41–76) underwent wholly endovascular repair of TAAA (diameter 56–85 mm)
employing individually customised endografts incorporating branches to 23
target vessels (renal 11, superior mesenteric 6, coeliac 6). The procedures were
performed under general anaesthesia with spinal drainage. Patients have been
followed by serial imaging (CT and duplex) for a median of 13 months (range
5–40). All data were prospectively entered onto a dedicated database.
Results: All grafts were deployed as intended with preservation of all target
vessels. There were no postoperative deaths, strokes or paraplegia. One patient
suffered a silent myocardial infarction. In two patients a persistent para-ostial
endoleak was successfully treated during the same admission by further balloon
dilatation of the stent within the target vessel ostium. Pre-discharge imaging
confirmed exclusion of the aneurysm in all cases. One patient has required late
secondary intervention to abolish endoleak due to sidebranch disconnection.
In another patient late occlusion of the solitary renal artery has resulted in
dependence on dialysis. There have been no late deaths and all aneurysms
remain excluded.
Conclusion: Both open surgical and hybrid endovascular/surgical treatments
of TAAA are associated with significant morbidity and mortality. A purely
endovascular approach is feasible and relatively safe, but long-term follow-up is
required to establish the durability of this technique.
Hybrid procedures for thoraco-abdominal aneurysms and secondary
expanding aortic dissections - intermediate results in three European
vascular centres
H. H. Eckstein
On behalf of the Regional Vascular Unit, St Mary’s Hospital, London and the
Departments of Vascular and Endovascular Surgery, University of Heidelberg,
Heidelberg, Germany and Technical University of Munich, Munich, Germany
Introduction: To evaluate the combined approach of visceral/renal
debranching and endovascular exclusion (hybrid procedure) of thoraco-
abdominal aneurysms and secondary chronic aortic dissections.
Methods: Consecutive data of three major European vascular units were
collected between 2002 and 2007 including a series of 89 symptomatic and
elective high risk patients. Eighty- seven patients had Types I–III degenerative
thoraco-abdominal aortic aneurysms. Twenty-four of these patients had a
chronic expanding dissection, three had a mycotic aneurysm and eight had
Marfan’s syndrome.
Results: All stent grafts involved the entire thoracic and abdominal aorta with
arch vessel revascularisation in 11 and coverage of the left subclavian artery in
18. The distal landing zone was in the infrarenal aorta in 75% and in the iliac
arteries in 25%. The 30-day mortality rate was 12/89 (13%). Seven (8%) of
the patients were permanently paraparetic or paraplegic, three patients (3%)
required long-term dialysis, and a segment of gut infarction requiring resection
occurred in 2 (2%). Graft occlusion at 30 days occured in 19/297 (6%). Most
patients had visceral revascularisation and stenting performed at the same time,
but in 11 patients the stenting was performed at a later date. Two of these
patients ruptured before the stenting procedure was undertaken.
Conclusion: Early results of visceral hybrid repair for high risk patients with
complex thoraco-abdominal aneurysms indicate that this technique might be
a valid alternative to open thoraco-abdominal aortic repair. Mid-term results
with respect to survival, graft patency and endoleak rates will be presented.
Neurological complications of thoracic endovascular aneurysm repair
(TEVAR): overstenting of the left subclavian artery (LSA) without
revascularisation is unsafe
P. L. Harris1, J. Buth2, R. Hobo2, R. van Eps2, on behalf of the
EUROSTAR participants
1University of Liverpool, Liverpool and 2EUROSTAR Data Registry Centre,
Catharina Hospital, Eindhoven, The Netherlands
Introduction: To determine the incidence of, and risk factors for, neurological
complications associated with TEVAR.
Methods: Data from 606 patients entered onto a multicentre international
registry were analysed. Thoracic aortic pathologies included: true aneurysm
(n = 291), dissection (n = 215), traumatic rupture (n = 67), anastomotic
aneurysm (n = 24), infections and others (n = 9). Three hundred and seventy-
nine (62%) procedures were elective, 205 (34%) were urgent or emergencies
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and 20 (4%) were unclassified. Mean follow-up was 14·1 months (0–72). Study
endpoints were peri-operative spinal cord ischaemia (SCI) or stroke. Univariate
analysis and multivariate regression models were used to determine risk factors
for these neurological sequelae.
Results: Fifteen patients (2·5%) developed SCI and 19 (3·1%) stroke.
Two patients had both. Multivariate regression analysis showed that SCI
was independently correlated with: i) left subclavian artery covering without
revascularisation (P = 0·027, Odds Ratio [OR]= 3·9); ii) renal failure (P = 0·02,
OR = 3·6); iii) concomitant open abdominal aorta surgery (P = 0·037, OR
= 5·5); and iv) number of used stent grafts ≥ 3 (P = 0·043, OR 3·5). Stent
graft diameter confounded with the number of stent grafts and correlated also
with SCI (P = 0·009, OR = 5·2). Risk factors for peri-operative stroke were:
i) duration of the intervention (P = 0·0045, OR = 6·4); and ii) female gender
(P = 0·023, OR = 3·3). In patients with an overstented superior mesenteric
artery, the incidence of stroke without and with revascularisation was 26% and
0, respectively (NS).
Conclusion: Revascularisation of the LSA is indicated whenever this vessel is
overstented during the course of TEVAR.
Mid-term results of endovascular repair of isolated iliac artery
aneurysms
A. Bajwa, M. Davis, R. Qasabian, R. Bell, T. Carrell, P. R. Taylor,
C. Sandhu, R. Salter, T. Sabharwal, J. R. Reidy
Regional Vascular and Endovascular Unit, Guy’s and St Thomas’ NHS Foundation
Trust, St Thomas’ Hospital, London
Introduction: The evidence for the natural history of isolated iliac artery
aneurysms is poor, but repair is usually advised when the diameter reaches
3–4cm. Open surgery for iliac artery aneurysms is not without procedure-
related morbidity and mortality. We report our experience of endovascular
repair of isolated iliac artery aneurysms.
Methods: There were 50 patients, with 56 isolated iliac artery aneurysms,
treated from 1997–2007. Data were prospectively collected on a computerised
database with CT follow-up at three months, and annually thereafter.
Results: The median age was 74 years with a mean follow-up of 2·6 years
(range 3 months–8 years). Mean aneurysm diameter was 47mm (18–102 mm).
The aneurysms were localised to the common iliac artery in 49 patients and to the
internal iliac artery in one patient. There were six patients with short proximal
necks or bilateral aneurysms requiring a bifurcated aortic device. Technical
success was achieved in 49/50 patients. One failure was due to difficulty with
access and treated with open surgery. In-hospital mortality was 0/50, with five
deaths during the follow-up period, none of which were aneurysm-related. One
device occluded on day two postoperatively, and there were two late endoleaks
which were treated endovascularly. One late device occlusion was treated with a
femoro-femoral crossover graft. The overall intervention-free survival was 80%
at 2·6 years.
Conclusion: Endovascular repair of isolated iliac artery aneurysms is safe and
associated with good mid-term results. Long-term follow-up is essential.
The long-term impact of endovascular aneurysm repair on renal
function
T. J. Parkinson, P. Davey, J. D. Rose, M. G. Wyatt
Northern Vascular Centre, Freeman Hospital, Newcastle-upon-Tyne
Introduction: This study assesses renal function up to ten years following
endovascular aneurysm repair (EVAR) with both infrarenal (IR) and suprarenal
(SR) devices.
Methods: A prospectively maintained database was interrogated for
consecutive EVAR patients between 1996 and 2001. Patients were grouped
according to proximal fixation level. Renal function was recorded annually
by serum creatinine (sCr mmol/L) and Cockroft-Gault-derived creatinine
clearance (CrC ml/min). Changes in renal function were analysed using the
1-sample Wilcoxon Test within groups, and the Mann Whitney U test between
groups.
Results: One hundred and eighty EVARs were performed during this period:
88 IR devices (M: F; 78: 10, median age 71 years), 92 SR devices (M: F; 83: 9,
median age 75·5 years). Paired renal data were available for 130 patients (IR:
67; SR: 63) with a mean follow-up of 40·5 (range 0–120) months. Pre-operative
renal function was similar between groups with median sCr and CrC values
of 113 µmol/L and 57 ml/min (IR) and 108 µmol/L and 58 ml/min (SR), both
P = NS. Seven years post-EVAR there was no significant deterioration in renal
function within either the IR or SR group, with median sCr and CrC values
of 117 µmol/L and 56 ml/min, and 138 µmol/L and 41 ml/min (all P = NS),
respectively.
Conclusion: These results suggest long-term renal safety following EVAR,
although longer follow-up with greater patient numbers is needed to fully assess
the potential late changes following SR.
Pre-discharge duplex ultrasound scanning (DUSS) detects endoleaks
not seen on completion angiography and identifies patients requiring
early re-intervention
R. M. Sandford, M. J. Bown, C. Lopez-Espada, C. Graham,
N. J. London, R. D. Sayers
University of Leicester, Leicester
Introduction: Duplex ultrasound scanning (DUSS) has been shown to be
effective in the detection of endoleak following endovascular abdominal aortic
aneurysm repair (EVAR). The aim of this study was to evaluate the role of
DUSS in the immediate postoperative period prior to hospital discharge.
Methods: Patients undergoing EVAR at a single centre between July 1994
and July 2005 received pre-discharge DUSS and were then followed up. A
retrospective review was performed using hospital case notes, vascular database
records and imaging reports.
Results: Of the 333 patients who underwent EVAR during this period, 32 of
these were found to have an endoleak on DUSS performed prior to hospital
discharge (16 type 1, 12 type 2 and 4 type 3 endoleaks). Nineteen of these
(59%) were not visualised on intra-operative completion angiography. Twenty-
one leaks (66%) were either observed or had spontaneously sealed by the first
postoperative clinic visit. Ten leaks required intervention: eight endovascular
procedures and two conversions to open repair. There was one death due to
rupture prior to intervention.
Conclusion: This study confirms that a significant number of early leaks are
not demonstrated on intra-operative angiography and a proportion of these are
likely to require secondary procedures to prevent aneurysm rupture and death.
This therefore confirms the role of pre-discharge DUSS in the detection and
treatment of early endograft failure.
Elective open and endovascular aortic aneurysm repair: a
meta-analysis of 20,715 patients
R. E. Lovegrove, M. Javid, T. M. Magee, R. B. Galland
Royal Berkshire Hospital, Reading
Introduction: A number of studies have compared outcomes following elective
open and endovascular (EVAR) approaches to abdominal aortic aneurysm (AAA)
surgery with varying reported benefits of EVAR.
Methods: A random-effects meta-analysis was conducted including all
published studies comparing open and endovascular approaches to elective
AAA repair. Study endpoints consisted of operative outcomes, postoperative
complications, 30-day mortality and long-term patient survival. Endpoints were
compared using the odds ratio (OR), weighted mean difference (WMD) or log
hazard ratio (HR) as appropriate.
Results: Thirty-two studies (four randomized trials) comprising 20,715
patients (51·0% open; 49·0% EVAR) were included. EVAR was associated with
reduced operating times (WMD-14·7 min; P = 0·02) and a reduction in intra-
procedure blood loss (WMD −1009 ml; P < 0·001). The duration of intensive
care stay was reduced in the EVAR group (WMD −36 hours; P < 0·001) and
postoperative length of stay (WMD-5·4 days; P < 0·001). Postoperative cardiac
(OR 1·76, P = 0·002) and respiratory (OR 4·01, P < 0·001) complications were
more common following open surgery as was 30-day mortality (OR 2·18,
P < 0·001). However, EVAR was associated with a trend towards an increased
re-intervention rate (OR 1·96, P = 0·08). EVAR was associated with improved
long-term aneurysm-related mortality rates (HR 0·39, P < 0·001) but did not
affect long-term all-cause mortality (HR 0·94, P = 0·52).
Conclusion: EVAR offers clear benefit in the reduction in postoperative
adverse events and 30-day mortality. In the longer term there is a reduction in
aneurysm-related mortality, but EVAR does not reduce all-cause mortality.
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Endovenous laser ablation (EVLA): is standard above-knee great
saphenous vein (AK-GSV) ablation sufficient? A randomised
controlled trial
S. N. Theivacumar, D. Dellagrammaticas, R. J. Darwood, A. I. D. Mavor,
M. J. Gough
Leeds Vascular Institute, The General Infirmary at Leeds, Leeds
Introduction: AK-GSV EVLA is an alternative to saphenofemoral (SF)
ligation and GSV stripping for primary varicose veins due to SF/GSV
reflux. Concomitant phlebectomies or delayed sclerotherapy are performed
for the varicosities. This RCT assesses whether extended GSV ablation
increases spontaneous resolution of varicosities and reduces adjuvant therapy
requirements.
Methods: Sixty-eight limbs (65 patients) with varicosities due to combined
above and below-knee GSV reflux were randomized to standard AK-EVLA
(group A, n = 23), extended EVLA (mid-calf to groin: group B, n = 23) or
AK-EVLA with concomitant BK-GSV foam sclerotherapy (group C, n = 22).
Outcome measures were the presence of residual varicosities at six weeks
(requiring sclerotherapy), improvement in the Aberdeen Varicose Vein Severity
Score (AVVSS) at 12 weeks, patient satisfaction (visual analogue scale) and
complication rates.
Results: EVLA ablated the treated GSV in all limbs. Sclerotherapy
requirements were: group A 14/23 (61%); group B 4/23 (17%); group C 8/22
(36%); χ2 = 9·3 (2 d.f.) P = 0·01; pA-B = 0·006; pB-C = 0·19; pA-C = 0·14.
AVVSS scores (median±IQR) improved in all groups (P < 0·001): group A:
14·8 (9·3–22·6) to 6·4 (3·2–9·1), group B: 15·8 (10·2–24·5) to 2·5 (1·1–3·7),
group C: 15·1 (9·0–23·1) to 4·1 (2·3–6·8). Improvements were greatest in
groups B and C (pA-B = 0·011, pA-C = 0·042). Patient satisfaction was highest
in group B. BK-EVLA was not associated with saphenous nerve injury.
Conclusion: Extended EVLA for patients with combined AK and BK-GSV
reflux appears safe, increases spontaneous resolution of varicosities and enhances
symptom improvement. Similar benefits occurred after concomitant BK-GSV
foam sclerotherapy and this technique may be useful when BK-GSV tortuosity
precludes extended EVLA.
Endovenous laser therapy with concomitant or sequential
phlebectomy: a randomized controlled trial
A. I. Mekako, J. Hatfield, M. N. A. Abdul Rahman, S. Gulati,
P. T. McCollum, I. C. Chetter
Academic Vascular Surgery Unit, Hull Royal Infirmary, Hull
Introduction: Significant proportions of patients require secondary procedures
such as sclerotherapy or phlebectomy following endovenous laser therapy
(EVLT) for varicose veins. We compared EVLT plus concomitant phlebectomy
(EVLTAP) with EVLT only.
Methods: EVLT patients were randomized to undergo concomitant
phlebectomy (n = 18), or no phlebectomy (n = 18), and followed up for
12 weeks. Procedure duration, pain scores, return to work/normal activities,
patient satisfaction, quality of life (QoL) outcomes, venous clinical severity
scores (VCSS), and need for secondary intervention were compared. Results are
median (inter-quartile range); P- value.
Results: EVLTAP took longer than EVLT only: 67 (51–78) min vs. 46
(38–56) min; P = 0·003. Pain scores, time to work/normal activities, and patient
satisfaction were similar. EVLTAP patients had lower Aberdeen Varicose Vein
Scores at 6 weeks (7·12 [2·00–11·56] vs. 14·74 [10·54–18·07]; P = 0·001) and
12 weeks (2·06 [0·00–6·71] vs. 9·60 [7·08–13·39]; P = 0·009). There were no
significant differences between groups in any SF-36 domain at any time point.
VCSS was significantly better in the EVLTAP group at 12 weeks. Six patients
(35%) in the EVLT only group required subsequent phlebectomies, while none
required secondary procedures following EVLTAP.
Conclusion: EVLTAP results in better clinical and disease-specific QoL
improvement than EVLT only, in the short term. Although the procedure
duration is longer, it neither increases pain nor delays return to work, and it
obviates the short-term need for secondary procedures.
No advantage in performing flush saphenofemoral ligation: results of
a randomised trial
R. J. Winterborn, C. Foy, J. J. Earnshaw
Gloucestershire Royal Hospital, Gloucester
Introduction: The aim of this study was to assess the role of different
techniques of saphenofemoral ligation in the reduction of neovascularisation
and recurrence following surgery for primary varicose veins.
Methods: One hundred and eighty-two patients (210 legs) with primary
saphenofemoral junction incompetence were randomized to standard saphe-
nofemoral ligation (transfixion with an absorbable suture) (SSL) or flush
saphenofemoral ligation (oversewing with 4/0 polypropylene) (FSL). All legs
underwent great saphenous vein stripping and multiple phlebectomies. Patients
underwent assessment pre-operatively, and at 6 weeks, 1 year and 2 years post-
operatively with clinical examination, duplex imaging and completion of the
Aberdeen Varicose Vein Symptom Severity Score (AVVSSS).
Results: A total of 168 patients (199 legs) attended for assessment at 6 weeks,
154 patients (181 legs) at one year and 148 patients (172 legs) at 2 years.
At 2 years, recurrent varicose veins were visible in 30 legs (33%) in the SSL
group and 26 legs (32%) in the FSL group (P = 0·90). Neovascularisation was
present in 20 legs (22%) in the SSL group and 15 legs (19%) in the FSL group
(P = 0·57). Nine cases of neovascularisation in the SSL group and five in the
FSL group directly resulted in clinical recurrence (P = 0·37). There was no
statistically significant difference in quality of life scores between the groups at
any follow-up.
Conclusion: Flush ligation of the saphenofemoral junction does not
significantly decrease the rate of neovascularisation or clinical recurrence
compared with standard transfixion ligation.
Duplex ultrasound appearances at one year after endovenous laser
ablation
S. M. Khan, G. Jass, J. Tappenden, P. D. F. Dodd
Sheffield Vascular Institute, Northern General Hospital, Sheffield
Introduction: To evaluate the incidence, pattern and significance of venous
reflux after endovenous laser ablation.
Methods: Reflux or recanalisation after endovenous laser ablation (EVLA)
might indicate potential for clinical varicose vein recurrence. Whilst early
reports for EVLA have been favourable, longer-term outcome remains
unknown. Duplex ultrasonography was performed 12 months after EVLA.
The incidence, site and clinical sequelae of reflux/recanalisation were analysed.
The energy delivered was compared between the groups, as this has been
reported as a significant factor.
Results: One hundred and nine duplex scans were reviewed. In 47 there was no
reflux/recanalisation. In 62 reflux/recanalisation was reported. Groin tributary
reflux was found in nine cases, distal reflux in 23, and recanalisation of the treated
vein was reported in 35. In five cases this was reported as total recanalisation,
although in two of these the vein was competent. Further treatment of the
35 cases in which recanalisation was found was as follows: sclerotherapy = 7,
repeat EVLA = 2, surgical saphenofemoral disconnection = 1. Mean energy
delivery was similar between the groups with or without reflux/recanalisation
(62·62 J/cm; SD 12·5 vs. 59·9 J/cm; SD 13: Wilcoxon, P = 0·22), or within the
different reflux categories (ANOVA, P = 0·18).
Conclusion: Reflux or recanalisation 12 months after EVLA were surprisingly
common. However, clinically significant events were rare. Although commonly
found on duplex (35/109), partial recanalisation does not appear to be of major
clinical significance in the first year. Laser energy delivered was not found to be
a factor in duplex evidence reflux or recurrence.
Endovenous laser ablation (EVLA) for short saphenous vein (SSV)
incompetence
N. Nwaejike, P. D. Srodon, C. Kyriakides
Barts and the London NHS Trust, The London Independent Hospital, and the Queen
Mary, School of Medicine and Dentistry, London
Introduction: Open surgery for SSV incompetence can lead to incomplete
surgery if the saphenopopliteal junction (SPJ) is not correctly identified. Other
possible complications are sural nerve damage and wound infection. The
objective is to present EVLA as a safe alternative to open surgery for SSV
incompetence.
Methods: Data prospectively collected on patients who had EVLA for varicose
veins were obtained from our dedicated vascular registry. From April 2005 to
June 2007 we performed EVLA on 204 limbs for varicose veins. Patients were
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offered an outpatient appointment at 6 weeks post-op. Subsequent follow-ups
were by phone consultation with further outpatient appointments as indicated.
Results: Thirty-five (17%) patients (24 female) with a mean age 47 years
(range 23–80 years) had EVLA for SSV incompetence. The mean length of
vein treated was 18cm (range 5–33 cm). The mean total energy given was 993J
(range 45–55 J/cm). Twenty-five procedures were done as day case and ten
as inpatient. Fifteen were done under general anaesthetic and 20 under local
anaesthetic. Obliteration of the SPJ was confirmed by ultrasound in all patients
postoperatively. There were no intra-operative complications. Two patients
developed superficial thrombophlebitis that resolved with non-steroidal anti-
inflammatory therapy. One patient developed a haematoma that completely
resolved in 2 weeks. There was no incidence of sural nerve injury or wound
infection.
Conclusion: We believe that EVLA is a safe minimally invasive alternative for
the surgical treatment of SSV incompetence.
Foam sclerotherapy improves venous function in limbs with chronic
venous ulceration
S. R. Kulkarni, R. A. Bulbulia, F. Slim, L. Emerson, J. Minor, C. Wakely,
K. R. Poskitt
Department of Vascular Surgery, Cheltenham General Hospital, Cheltenham
Introduction: Superficial venous surgery has been shown to improve venous
function in limbs with chronic venous ulceration. The aim of this study was to
assess the haemodynamic effects of duplex-guided foam sclerotherapy in limbs
with superficial venous reflux and chronic venous ulceration.
Methods: Ulcerated limbs (CEAP 5 and 6) with superficial venous reflux were
treated with foam sclerotherapy and compression bandaging. Venous duplex
imaging was performed before and following completion of treatment. Venous
function of limbs was assessed by measuring venous refill times (VRTs) before
and following completion of treatment using digital photoplethysmography.
Results: Thirty-four limbs (CEAP 5: n = 24, CEAP 6: n = 10) were treated
with foam sclerotherapy between July 2006 and June 2007. Complete occlusion
of the treated veins occurred in 25/34 limbs (74%) after one treatment and in
30/34 (88%) limbs after second treatment. Following foam sclerotherapy, VRT
increased in 29/34 limbs. Overall median (range) VRT increased from 11·5s
(3–26) to 21s (8–48) after foam sclerotherapy (P < 0·001, Wilcoxon signed
rank test). Of the ten active ulcers at the time of sclerotherapy, seven healed
(70%) at a median of 3 weeks.
Conclusion: Our early experience of foam sclerotherapy for chronic venous
ulceration shows an improvement in venous function following treatment.
Whilst longer-term follow-up is required to see whether this is maintained,
sclerotherapy may be an acceptable alternative to surgery in this group of
patients.
Transcranial Doppler-directed intravenous glycoprotein IIb/IIIa
receptor antagonist therapy to control transient cerebral micro-emboli
D. van Dellen, C. A. S. Tiivas, C. Marshall, D. J. Higman, C. H. E. Imray
Coventry and Warwickshire County Vascular Unit, University Hospital Coventry and
Warwickshire, Walsgrave Hospital, Coventry
Introduction: Patients with transient focal neurological deficits, critical carotid
stenoses and transcranial Doppler (TCD) ultrasound-detected micro-embolic
signals (MES) have a significant risk of stroke. There is evidence that a high
embolic load post-carotid surgery may result in strokes. We assessed the effect
of tirofiban, a highly selective glycoprotein IIb/IIIa (GPIIb/IIIa) inhibitor,
in suppressing MES in patients with symptomatic transient ischaemic attacks
(TIAs) and postoperative carotid endarterectomy (CEA).
Methods: Thirty-three patients with ongoing MES (13 symptomatic pre-
operative, 19 postoperative, 1 both) were treated with tirofiban between August
2002 and March 2007. All patients had > 70% carotid stenosis and underwent
TCD monitoring during and after tirofiban therapy.
Results: With treatment, the MES rate decreased from a median (range)
of 22 (4–260) pre-operatively and 81 (44–216) postoperatively to a median
of 0 (0–9) (P < 0·0001; Mann Whitney test) in both groups. This occurred
rapidly (pre-operative: median 30 min; postoperative: median 45 min) and was
well tolerated in all patients. There were no serious adverse effects with one
haematoma requiring evacuation.
Conclusion: Cerebral micro-emboli appear to result from platelet aggregation
on unstable carotid plaques or recently endarterectomised tissue. The aggregates
are well controlled by GPIIb/IIIa antagonists which appear to offer a novel
effective method of controlling MES with safe, symptomatic relief in pre- and
postoperative patients undergoing carotid endarterectomy. Further study would
be required to compare the relative efficacy of GPIIb/IIIa inhibitors and the
established drug Dextran 40.
Can SF8 replace SF36 as quality of life analysis in patients with lower
limb ischaemia?
S. Gulati, P. A. Coughlin, M. N. A. Rahman, A. Mekako, J. Hatfield,
B. Akomolafe, P. Renwick, P. T. McCollum, I. C. Chetter
Academic Vascular Surgery Unit, Hull Royal Infirmary, Hull
Introduction: Generic quality of life (QoL) is a crucial outcome measure
in patients with lower limb ischaemia (LLI) with the Short Form 36 (SF36)
accepted as the gold standard instrument. We aimed to assess whether the new,
shorter, simplified Short Form 8 (SF8) is sufficiently responsive to replace SF36
in LLI.
Methods: One hundred and ninety-three patients, 135 men, median age
66 years (range 44–84 years) with LLI completed the SF36 and SF8. Patients
were graded according to ISCVS standards, i.e. 30 mild, 52 moderate, 73
severe claudicants; 16 rest pain and 21 tissue loss. Both instruments assess the
same eight QoL domains. Validity: convergent-divergent and construct validity
were assessed for both QoL instruments. Reliability: test-retest reliability was
assessed in a subgroup of 60 patients. Responsiveness: between grades of LLI
was also analysed with non-parametric statistical tests.
Results: Validity: a) convergent-divergent validity. There was greater
correlation between like domains of the SF36 and SF8 (0·594–0·792, P = 0·000)
than the non-like domains, suggesting good convergent-divergent validity;
b) construct validity. The SF36 and SF8 demonstrated similar construct
validity. Reliability: both QoL instruments were significantly reliable (rs > 0·7).
Responsiveness: increasing LLI resulted in a statistically significant deterioration
in all eight domains of both the SF8 and SF36 (P < 0·05, Kruskal-Wallis
ANOVA).
Conclusion: The SF8 is a valid and reliable generic QoL instrument in patients
with LLI. It demonstrates similar responsiveness as the SF36 in these patients
and as it is simpler and quicker to complete, we suggest it to replace the SF36
as the gold standard generic QoL analysis in LLI.
Subintimal angioplasty (SIA) vs bypass surgery (BS) for critical lower
limb ischaemia in patients with TASC C and D lesions: a 5-year
prospective observational comparative study
N. Hynes, S. Sultan
Western Vascular Institute, Galway, Republic of Ireland
Introduction: Appropriate revascularisation results in high patency and
significantly reduces amputation rates. Our primary aim is to evaluate SIA
and BS in maintaining amputation- free survival. Secondary endpoints are to
investigate whether SIA reduces the risk of major adverse events (MAE) and
enhances quality time without symptoms of disease or toxicity of treatment
(Q-TWiST) in a cost-effective manner.
Methods: From 2002–2007, 1276 patients were referred with peripheral
vascular disease. We performed a prospective parallel group comparison of
334 primary procedures (SIA = 206, BS = 128) in 309 patients (nSIA = 190,
nBS = 119) with CLI. Mean age (SIA 73+/−13 years vs. BS 70+/−14 years,
P = 0·127) and comorbidity severity scores (P > 0·05) were similar between
groups. However, 55% were females in the SIA group vs. 35% in BS, P = 0·0005.
Results: Five-year amputation-free survival rates were similar: SIA (72·9%)
vs. BS (71·2%), P = 0·9765. Five-year primary patency was: SIA 72·8% vs.
BS 65·3%, P = 0·7001. Five-year assisted primary patency was improved with
SIA, 82·8% vs. BS 68·2%, P = 0·1061. Five-year secondary patency rates were
SIA 85·9% vs. 72·1%, P = 0·2624. Mean number of procedures (+/− SD) for
SIA was 1·19+/−0·50 and for BS was 1·10+/−0·41, P = 0·078. Risk of MAE
(P < 0·002) and length of hospital stay (LOS) (LOS SIA 14+/−16 days vs.
LOS BS 24+/−23 days, P < 0·0001) were significantly reduced with SIA. Q-
TWiST was significantly improved (P < 0·001) and cost per Quality Adjusted
Life Years (QALY) (P < 0·05) was reduced with SIA. Five-year survival rates
were comparable.
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Conclusion: SIA enhances symptom-free survival rates without MAE and
further Q-TWiST. It is cost effective, allowing for a high patient turnover
without compromising QALY and is technically successful in most patients. SIA
is the gold paradigm in the management of CLI.
Fast-track open aortic surgery: reduced postoperative stay with a
goal-directed pathway
M. A. Murphy, T. Richards, C. Atkinson, J. Perkins, L. J. Hands
John Radcliffe Hospital, Oxford
Introduction: Open aortic aneurysm repair is traditionally associated with an
extended hospital stay. The aim of this study was to examine the feasibility
of reducing postoperative stay through the implementation of a fast-track,
goal-directed, clinical pathway for elective open aortic surgery.
Methods: A fast-track clinical pathway for aortic surgery was introduced
in a regional vascular unit in September 2005. The pathway has daily goals
and discharge is targeted for all patients on the third postoperative day. This
study compares 30 consecutive discharges of unselected patients undergoing
elective infrarenal aortic surgery following introduction of the pathway to the
30 consecutive cases preceding its introduction. Reasons for prolonged hospital
stay were recorded.
Results: Six of 30 patients achieved discharge by day three. The median
hospital stay reduced from 9 (range 4–17 days) to 5 days (range 2–12 days)
following introduction of the pathway. There was one readmission within
30 days and no complications attributable to the pathway implementation.
Cardiac complications and home planning were the most common causes of
delayed discharge.
Conclusion: Postoperative stay in patients undergoing standard elective open
infrarenal aortic surgery can be safely reduced with the introduction of a
goal-directed pathway.
Does aneurysm rupture risk decrease in patients who are
anatomically suitable for endovascular repair?
EVAR 2 Trial Participants
Imperial College, London
Introduction: To investigate factors associated with large abdominal aortic
aneurysm (AAA) rupture in patients anatomically suitable for endovascular
repair but considered unfit for open surgery.
Methods: Patients randomised in the EVAR 2 trial (n = 404 by August 2004)
were followed up until December 2005 for AAA rupture. Patients without
rupture were censored as non-emergency AAA repair, death, loss to follow-up
or known emigration, or end of follow-up period. Cox regression, adjusted
for baseline covariates, was used for analysis of pre-specified factors (gender,
diabetes, initial AAA diameter, aneurysm neck and sac lengths) associated with
rupture.
Results: The overall rupture rate in EVAR 2 was 15·6 (95% c.i. 11·6–20·6)
per 100 patient years and for those with 6+ cm aneurysms, 17·4 (95% c.i.
12·9–23·4) per 100 person-years, appeared to be significantly lower than that
from meta-analysis of other studies, 27·0 (95% c.i. 21·1–34·7) per 100 person-
years, P = 0·026. Patients with shorter neck lengths appeared to have a higher
rupture rate than those with longer necks, but this was of borderline significance
(P = 0·10). Patients with diabetes also showed a trend towards lower rupture
rates. The covariate baseline statin usage appeared to reduce the rupture rate.
Post-hoc analysis showed that patients taking statins at baseline had half the
rupture rate of non-statin patients, HR 0·52 (95% c.i. 0·27–0·98), P = 0·044,
which was similar after adjustment for other baseline covariates.
Conclusion: This study supports the hypothesis that patients anatomically
suitable for endovascular repair have lower AAA rupture rates than patients who
are not anatomically suitable for endovascular repair. The possibility that statins
reduce rupture rates should be tested prospectively.
Recurrence and neovascularisation two years after varicose vein
treatment: a comparison of surgery and endovenous laser ablation
(EVLA)
N. S. Theivacumar, R. J. Darwood, A. I. D. Mavor, M. J. Gough
Leeds Vascular Institute, The General Infirmary at Leeds, Leeds
Introduction: Recurrent varicosities following previous treatment are
common with neovascularisation being a major cause after conventional surgery.
This study compares recurrence rates and the incidence of neovascularisation
following surgery (saphenofemoral [SF] ligation, stripping above-knee great
saphenous vein [GSV]) and above-knee GSV EVLA.
Methods: One hundred and twenty-nine consecutive limbs (118 patients: 72
females, 46 males, median age 48 [32–68]) underwent treatment (group A:
surgery, n = 60 limbs; group B: EVLA n = 69 limbs) for primary SF/GSV
reflux over 17 months and were reviewed at a mean of 24 months (range
18–30). Clinical varicose vein recurrence, duplex ultrasound- detected groin
neovascularisation and patient satisfaction (visual analogue scale) were recorded.
Statistical analysis used the Fisher exact test to compare recurrence and
neovascularisation rates, and unpaired student t-tests to compare patient
satisfaction.
Results: Recurrence rates at 2 years were: group A 4/60 (6·6%); group B 5/69
(7%), (P = 0·631). The causes of recurrence were: group A: mid-thigh perforator
n = 2, residual GSV with neovascularisation n = 2; group B: GSV recanalisation
n = 3 (all received < 50 J/cm laser energy), mid-thigh perforator n = 1, new
anterior saphenous vein reflux n = 1. Neovascularisation was detected in 11/60
(18%) of group A and 1/69 (1%) of group B, P = 0·001. Patient satisfaction was
90% and 88%, respectively (P = 0·37).
Conclusion: Although there was no difference in the frequency of recurrent
varicose veins following conventional surgery or EVLA at 2 years, the incidence
of neovascularisation, a predictor of future recurrence, was significantly lower
following laser therapy. Further, current recommendations to deliver ≥ 70 J/cm
laser energy should reduce the risk of recanalisation and recurrence in EVLA
patients.
A randomized placebo-controlled double-blind trial to evaluate
ezetimibe combination therapy on abdominal aortic aneurysm wall
proteolysis and inflammation
J. Dawson, E. Choke, G. Cockerill, I. Loftus, J. Derodra, R. McFarland,
T. Loosemore, M. Thompson
St George’s Vascular Institute, St George’s Hospital, London
Introduction: HMG-CoA reductase inhibitors (statins) have the potential to
retard abdominal aortic aneurysm (AAA) growth. Statins have been associated
with suppression of aneurysm formation in a murine model, and reduced
concentrations of aneurysm wall MMP-9 and IL-6 in humans. These effects
may be consequent upon a reduction in serum LDL-C. Ezetimibe is a novel
cholesterol absorption inhibitor used in combination with statins to lower LDL-
C. This study aimed to compare the biological effects of combining ezetimibe
and simvastatin with the actions of simvastatin alone on parameters relevant to
aneurysm expansion.
Methods: In a double-blinded randomized controlled trial, nine patients
scheduled for elective open AAA repair were randomized to simvastatin 40 mg
+ ezetimibe 10 mg daily and nine to simvastatin 40 mg + placebo. Total
concentrations of TNF-a, IL-1b, IL-6, IL-8, IL-10, MMPs-1,-2,-3,-8,-9,-12,-
13, TIMP-1 and TIMP-2 were measured in plasma, aortic wall homogenates
and tissue culture explants. Median trial duration was 30 days.
Results: Two patients in the placebo arm underwent EVAR precluding aortic
samples. There were no significant differences in plasma levels between groups.
There were significant reductions in aortic wall MMP-9 (P = 0·016) and IL-
10 (P = 0·03) concentrations associated with ezetimibe use. Tissue culture
revealed a significant reduction in MMP-1 (P = 0·02), MMP-2 (P = 0·02) and
IL-6 (P = 0·02) in the ezetimibe group.
Conclusion: These results suggest that ezetimibe combination therapy
reduces aortic wall proteolysis and inflammation, key processes that drive
AAA expansion. A larger RCT is justified focusing on aneurysm growth rates in
small AAA.
Surgical versus endovascular reconstruction for chronic mesenteric
ischaemia
R. S. M. Davies, M. L. Wall, S. H. Silverman, R. K. Vohra,
A. W. Bradbury, D. J. Adam
University Department of Vascular Surgery, Heart of England NHS Foundation
Trust, Birmingham and the Department of Vascular Surgery, University Hospital
Birmingham NHS Foundation Trust, Birmingham
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Introduction: To compare the immediate and long-term outcomes of surgical
(SR) and endovascular (ER) reconstruction for chronic mesenteric ischaemia
(CMI).
Methods: Retrospective review of consecutive patients who underwent SR
or ER for CMI in three vascular surgery units in the UK between 1996 and
2006. Early (< 30 days) outcome (technical success, major morbidity, mortality,
length of hospital stay) and late (> 30 days) outcome (symptom recurrence,
vessel/graft patency, re-intervention, mortality) were assessed.
Results: Twenty-six patients underwent 32 mesenteric arterial reconstruc-
tions: SR (n = 18), ER (n = 14). Comorbidity and anatomical distribution of
mesenteric disease did not differ between the two groups. Forty-three of 58
(74%) diseased arteries were revascularised. Twenty-six vessels underwent SR
(bypass [n = 25], endarterectomy [n = 1]) for stenosis in 14 (54%) and occlusion
in 12. Seventeen vessels underwent ER for stenosis in 15 (88%) and occlusion
in two. Peri-operative mortality for SR and ER was 6% and 0%, respectively
(P = 0·56). Hospital stay was significantly shorter following ER compared to
SR (mean, 4·5 vs. 14·8 days; P = 0·0003). ITU admission was significantly more
likely following SR compared to ER (P < 0·0001). Mean (range) follow-up for
SR and ER was 30 (1–94) months and 33 (0–135) months, respectively. At
two years, there was no significant difference between SR and ER for primary
patency (83% vs. 50%), secondary patency (87·5% vs. 62%), clinical patency
(90% vs. 79%) and re-intervention-free survival (65% vs. 57%).
Conclusion: ER is associated with significantly shorter hospital stay and
comparable long-term outcome as SR and represents an acceptable first-line
treatment option in appropriately selected patients with CMI.
Driving advice given by vascular surgeons: a survey of Vascular
Society Members
R. Gohil, D. A. Russell, B. F. Johnson
Academic Vascular Surgery Unit, Hull Royal Infirmary, Hull
Introduction: It is a legal requirement of doctors to assess all patients’ fitness
to drive based on DVLA guidelines. Our aim was to assess the current advice
given to patients by vascular surgeons and compare this to national guidelines.
Methods: A postal survey was performed of 438 members of The Vascular
Society. Six questions covered a spectrum of scenarios commonly seen in
vascular surgical practice. Options were provided in line with DVLA guidelines
for domestic driving.
Results: The response rate was 52·5% (n = 230). Thirty-three (14·3%) gave
no driving advice for any scenario, whereas no respondents gave answers in
keeping with guidelines for all scenarios. Two hundred and twenty-six (98·3%)
gave correct advice for claudicants. Patients with a single TIA were stopped from
driving inappropriately in 40·3% of cases, whilst those with multiple TIAs were
allowed to drive inappropriately in 27·0%. By contrast patients with a 5·5cm
AAA were prevented from driving inappropriately in 6·6% of cases, whilst those
with a 6·5cm AAA were incorrectly allowed to drive in 74·6%. Advice given
to patients with a peri-operative MI was highly variable (appropriate in 32
[19·9%]).
Conclusion: Current driving advice given by members of The Vascular
Society is highly variable. Patients with TIA are likely to be given correct or
over-cautious advice, whereas those with aneurysmal disease are more likely to
be allowed to drive against DVLA guidelines. Further education of vascular
surgeons regarding driving advice and, perhaps, re-appraisal of guidelines, are
required.
The value of graft surveillance in infra-inguinal bypasses performed
with small diameter veins
R. Mofidi, P. Sanjay, M. Flett, J. Nagy, G. D. Griffiths, P. A. Stonebridge
East of Scotland Vascular Network, Ninewells Hospital, Dundee
Introduction: Within the context of a surveillance programme, we sought
to assess the impact of pre-operative diameter of the venous conduit on re-
intervention rate and its relationship to outcome following infra-inguinal vein
graft bypass.
Methods: Consecutive infra-inguinal vein bypasses between January 2001
and December 2006 were reviewed. All patients underwent pre-operative vein
mapping and measurement of vein graft diameter (VGD). Grafts were classified
into those with VGD < 3·5mm or grafts with VGD ≥ 3·5mm. All patients were
enrolled in a duplex surveillance programme. The association between VGD
and re-intervention rate was assessed. Graft patency and amputation rates were
compared.
Results: Three hundred and seventy-seven bypasses were followed up for a
median of 21 months (range: 2–67). Forty-month primary, primary assisted,
and secondary patency were 73%, 79% and 83%. VGD was < 3·5 mm in 139
grafts (36·9%) and ≥ 3·5mm in 238 (63·1%). A higher proportion of smaller vein
grafts (32·3%) required re-intervention to maintain graft patency compared with
larger conduits (20·2%), (χ2 = 7·7, P < 0·001). VGD (odds ratio: 2·87 [95%
c.i.: 1·63–3·81], [P < 0·001]), smoking (odds ratio: 1·83 [95% c.i.: 1·39–3·20],
[P = 0·02]) and the type of bypass (odds ratio: 1·86 [95% c.i.: 1·49–2·47],
[P = 0·02]) were variables associated with a higher re-intervention rate. There
was no difference in graft patency (P = 0·13) or amputation rates (P = 0·35)
between the two groups, stratified on the basis of VGD.
Conclusion: Use of smaller vein grafts is associated with a higher re-
intervention rate. Provided that these grafts are surveyed and where necessary
repaired, the use of smaller vein grafts is successful and expands the availability
of autogenous conduit for infra-inguinal arterial reconstruction.
Abdominal aortic aneurysm screening - why wait?
A. Al-Allak, J. E. Thomas, S. Davies, A. R. Hedges
Bro-Morgannwg NHS Trust, Bridgend
Introduction: The introduction of an abdominal aortic aneurysm screening
programme, without additional funding, has been explored. The Trust serves
a population of 270,000. The aim of this study was to review feasibility, costs,
results and patient satisfaction two years after introduction.
Methods: Trust and LHB approval were obtained. ‘Second offer surgery’
funded two ultrasound machines. The vascular consultant and nurse specialist
performed the scans and the vascular secretary undertook all administration.
A patient satisfaction questionnaire was sent to a random selection of 150
patients with screened normal aortas and all patients who had screen-detected
aneurysms. The non-pay costs for running the programme were calculated.
Results: In the two-year period, 2946 patients were invited for an abdominal
ultrasound (2620 attended). Sixty-five aneurysms were discovered; seven
underwent surgery. There was a 71% return of questionnaires: 100% thought
the programme a good idea; 99% were happy with the organisation and would
encourage others to attend. Of those with screen-detected aneurysms, 100%
were happy that they had attended, but 20% felt their lifestyle was subsequently
affected. Non-pay costs totalled £1115·46 per year.
Conclusion: We have demonstrated that it is possible to introduce a screening
programme with no additional resources. The programme has been accepted
by patients. Patients with screen-detected aneurysms were happy to have had
them discovered but one in five felt their lifestyle was affected as a result of the
diagnosis. Annual non-pay costs of running the programme are minimal.
The role of pre-operative angiography in the morphological
assessment of ruptured abdominal aortic aneurysm
S. A. Badger, M. E. O’Donnell, N. Arya, W. Loan, R. J. Hannon,
L. L. Lau, B. Lee, C. V. Soong
Vascular and Endovascular Surgery Department, Belfast City Hospital, Belfast
Introduction: Angiographic aortic aneurysm neck visualisation is an alternative
to computerised tomography (CT) for endovascular aneurysm repair (EVAR),
with time-saving potential in the emergency setting. We evaluated angiography
in the assessment of aortic neck morphology as a complementary or replacement
investigation.
Methods: Patients admitted for elective or emergency EVAR were assessed
by pre-operative CT and intra-operative angiography. The proximal and distal
aortic neck diameters, and neck length were measured. Measurements were
expressed as mean (± standard deviation) and compared by Student’s t-test.
The correlation between measurements was assessed by Pearson’s correlation
coefficent.
Results: Thirty-five patients (20 male) were assessed from August 2003
to January 2005 for elective (26) and emergency (9) EVAR. The mean
proximal neck diameter was 22·33 mm (±3·21) on CT, or 21·22 mm (±4·25) on
angiography (P = 0·01). The mean distal neck diameter was 23·03 mm (±3·15)
on CT, or 22·75 mm (±4·67) on angiography (P = 0·29), while the mean neck
length was only slightly greater on angiography relative to CT (24·78 mm
±10·21 vs. 23·45 mm ±8·51; P = 0·76). There was a close relationship of
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results for the proximal neck diameter (r = 0·67, P > 0·0001), distal neck
diameter (r = 0·74, P > 0·0001) and neck length (r = 0·44, P = 0·02). The
stent grafts deployed were oversized by 26·76% (±14·84) relative to the CT
measurements, and 33·66% (±15·64) relative to angiographic measurements.
Conclusion: The use of on-table angiography appears to be an acceptable
alternative to determine the neck diameter and thus the stent graft size. Further
research is needed to ascertain the ultimate success of this investigative modality
in the emergency setting.
Endovascular vs. open repair of acute abdominal aortic aneurysms - a
meta-analysis
U. Sadat, S. R. Walsh, J. Boyle, P. D. Hayes
Addenbrooke’s Hospital, Cambridge
Introduction: To compare the results of emergency open repair of acute AAA
with that of endovascular repair.
Methods: A systematic literature search was performed to identify series that
reported comparative outcomes. PUBMED, Embase, the RCT register and
all relevant major journals were searched independently by two researchers.
Twenty-three studies were identified, out of which 22 studies were eligible. The
outcome measures were 30-day mortality, ITU stay, hospital stay, blood loss
and operative duration.
Results: The total number of patients in the pooled data was 7040, of which
730 belonged to the e-EVAR group. e-EVAR was associated with a significant
reduction in mortality (pooled odds ratio 0·624; 95% c.i. 0·518–0·752;
P < 0·0001). The EVAR group had a significantly shorter ITU stay (pooled
effect size estimate −0·70 days; 95% c.i. −1·05 to −0·35 days; P < 0·0001)
and significantly reduced hospital stay (pooled effect size estimate −0·33 days;
95% c.i. −0·50 to −0·16 days; P = 0·0001). EVAR was also associated with a
significant reduction in blood loss (pooled effect size estimate −1·88 litres; 95%
c.i. −2·49 to −1·27; P < 0·0001) and reduced procedure time (pooled effect size
estimate −0·65 hours; 95% c.i. −0·95 to −0·36 hours; P < 0·0001).
Conclusion: There has been debate about the benefit of EVAR in ruptured
AAA. This meta-analysis indicates clear benefits to the selected group of
patients undergoing this minimally invasive procedure. There is a reduction in
high mortality, prolonged intensive care requirement, total hospital stay, large
blood loss and operative duration which are historically associated with open
repair.
EVAR for emergency AAA: not an easier option!
T. Richards, S. Goode, G. Kuhan, S. Chandrashaker, W. Tennant,
S. MacSweeney, B. Braithwaite
Queen’s Medical Centre, Nottingham
Introduction: In 2004 the National Vascular Database mortality for ruptured
AAA was 41%. We wished to assess the results of EVAR for the management
of emergency AAA.
Methods: One hundred and forty-two patients underwent emergency EVAR.
Patient age, size of AAA and mode of presentation were compared. Mortality at
24 hours, 30 days and 12 months were compared. Causes of mortality were also
compared in particular cases where EVAR led to death.
Results: There were 51 acute ruptured AAA and 91 acute symptomatic AAA.
Women (26) were older than men (116) (average age 77 vs. 73 years, P = 0·009).
There was no difference in average AAA size (median 7·2 cm) between men
and women or mode of presentation. Mortality figures at 24 hours, 30 days and
12 months were: 16%, 29%, 49% for ruptured AAA and 12%, 24%, 37% for
symptomatic AAA. Mortality from ruptured AAA was greater at 12 months,
P = 0·046. Overall causes of death by 30 days were as expected (bleeding 8,
cardiac 5, organ failure 12, other 3); a further six deaths occurred due to EVAR
failure (persistent endoleak, renal artery occlusion, graft thrombosis). A further
four patients later died (3–7 years) following graft failure.
Conclusion: EVAR for emergency AAA is associated with increased
complications related to graft deployment. If these problems are overcome
then mortality may be lower.
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